MSN launches generic version of breast cancer drug Palborest

Palborest:-

MSN Group launched the ‘world’s first’ generic Palbociclib tablets indicated for advanced breast cancer therapy under the brand Palborest. Palbociclib is approved by the USFDA, EMA and CDSCO in combination with hormonal therapies for patients with hormone receptor positive, human epidermal growth factor receptor negative locally advanced or metastatic breast cancer.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

About Palborest:-

  1. Priced at ₹257 per tablet for 125mg, ₹233 per tablet for 100mg, ₹214 per tablet for 75mg respectively, Palborest is more affordable and bioequivalent to innovator tablet.
  2. The tablet dosage offers a distinct advantage over capsule dosage form as they can be taken with or without food.
  3. These tablets can be co- administered with proton pump inhibitors (PPIs) or antacids. The tablet formulation does not contain lactose (dairy) or gelatin, which also contributes to the efficacy of the drug.
  4. Palborest comes in a pack of 3 strips of 7 tablets each to meet the recommended 3-weeks on, 1-week off treatment schedule.

Proton Pump Inhibitors (PPIs):-

  1. Proton-pump inhibitors (PPIs) are a class of medications that cause a profound and prolonged reduction of stomach acid production. They do so by irreversibly inhibiting the stomach’s H+/K+ ATPase proton pump.
  2. They are the most potent inhibitors of acid secretion available. Proton-pump inhibitors have largely superseded the H2-receptor antagonists, a group of medications with similar effects but a different mode of action, and antacids.
  3. PPIs are among the most widely sold medications in the world. The class of proton-pump inhibitor medications is on the World Health Organization’s List of Essential Medicines. Omeprazole is the specific listed example.

What Is Breast Cancer?

Breast cancer is a disease in which cells in the breast grow out of control. There are different kinds of breast cancer. The kind of breast cancer depends on which cells in the breast turn into cancer.

Breast cancer can begin in different parts of the breast. A breast is made up of three main parts: lobules, ducts, and connective tissue. The lobules are the glands that produce milk. The ducts are tubes that carry milk to the nipple. The connective tissue (which consists of fibrous and fatty tissue) surrounds and holds everything together. Most breast cancers begin in the ducts or lobules.

Breast cancer can spread outside the breast through blood vessels and lymph vessels. When breast cancer spreads to other parts of the body, it is said to have metastasized.

Fig 1:- Anatomy Of Breast

Important Takeaway For All Exam:-

  • MSN Group – Founder, Chairman & Managing Director – Dr. MSN Reddy
  • MSN Group – Executive Director – Bharat Reddy
  • MSN Group Founded – Hyderabad 2003

More Sci-Tech News Here

 

 

 

Mahesh Kumar

Working as an SEO Manager at Adda247, I bring over 10 years of experience in Search Engine Optimization (SEO) and digital marketing. I specialize in driving organic growth through data-driven strategies, including keyword research, on-page SEO, off-page optimization, and technical SEO. My area of expertise in the EdTech sector, specifically focusing on competitive exams such as Bank, SSC, Railway, UPSC, and various State Government job examinations.

Recent Posts

Sowcar Janaki Dies at 94: Remembering a Legendary Career

Renowned Indian actress Sowcar Janaki breathed her last at the age of 94 on August…

14 hours ago

PM-AASHA Scheme 2026: Objectives, MSP Benefits, Components and Latest Updates

Pradhan Mantri Annadata Aay Sanrakshan Abhiyan (PM-AASHA) is an initiative of the central government that…

14 hours ago

Who Is Yu Zidi? Meet the 13-Year-Old Chinese Swimmer Set to Feature in Asian Games 2026

Many of the finest sport athletes of Asia will be participating in the Asian Games…

16 hours ago

What Is Analogue Paneer? Why States Are Banning It and What Consumers Need to Know

Paneer is one of the most popular and widely used ingredients in India. However, recently…

16 hours ago

Ashutosh Parida to Receive Sarala Puraskar 2026 for Poetry

Prominent Odia poet, essayist, and former scientist at CSIR-IMMT, Ashutosh Parida has been chosen for…

17 hours ago

RBI Appoints S Somanath, Reappoints Anand Mahindra to Central Board

The Reserve Bank of India has named former chairman of the Indian Space Research Organisation,…

17 hours ago